Zhenying Guo1, Chunwei Xu2, Shirong Zhang3

  • 1Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou 310014, China.

Cancer biology & medicine
|February 18, 2026
PubMed
概括

瘤突变负担 (TMB) 在预测免疫治疗反应方面表现有前途,但缺乏标准化. 这一共识为TMB测试和在中国的临床应用提供了建议,以改善患者护理.